RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Hansoh Pharmaceutical Group Company Stock

Hansoh Pharmaceutical Group Company Debt 2024

Hansoh Pharmaceutical Group Company Debt

-18,130.96 CNY

Ticker

3692.HK

ISIN

KYG549581067

WKN

A2PLRC

In 2024, Hansoh Pharmaceutical Group Company's total debt was -18,130.96 CNY, a 36.97% change from the -13,237.42 CNY total debt recorded in the previous year.

Hansoh Pharmaceutical Group Company Aktienanalyse

What does Hansoh Pharmaceutical Group Company do?

The Hansoh Pharmaceutical Group Co Ltd is a leading company in the pharmaceutical industry in China. It was founded in 1995 and has its headquarters in Lianyungang, with branches in Beijing and Shanghai. The company specializes in developing and producing innovative drugs for various diseases. It invests significant resources in research and development, collaborating with renowned research institutes and universities. Hansoh has a wide range of products in areas such as oncology, anesthesia, antibiotics, anti-infectives, and cardiovascular diseases. It has expanded its research and development activities in recent years and has partnerships with other pharmaceutical companies. The company mainly sells its products to hospitals and medical facilities in China. It is committed to strong corporate governance and sustainability, and it has been recognized for its environmental initiatives. Overall, Hansoh Pharmaceutical Group Co Ltd is a major player in the Chinese pharmaceutical industry. Hansoh Pharmaceutical Group Company ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding Hansoh Pharmaceutical Group Company's Debt Structure

Hansoh Pharmaceutical Group Company's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Hansoh Pharmaceutical Group Company's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Hansoh Pharmaceutical Group Company’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Hansoh Pharmaceutical Group Company’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Hansoh Pharmaceutical Group Company stock

What is the debt of Hansoh Pharmaceutical Group Company this year?

Hansoh Pharmaceutical Group Company has a debt level of -18,130.96 CNY this year.

What was the debt of Hansoh Pharmaceutical Group Company compared to the previous year?

The debt of Hansoh Pharmaceutical Group Company has increased by 36.97% compared to the previous year increased.

What are the consequences of high debt for investors in Hansoh Pharmaceutical Group Company?

High debt can pose a risk for investors of Hansoh Pharmaceutical Group Company, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of Hansoh Pharmaceutical Group Company?

Low debt means that Hansoh Pharmaceutical Group Company has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from Hansoh Pharmaceutical Group Company affect the company?

An increase in debt of Hansoh Pharmaceutical Group Company can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of Hansoh Pharmaceutical Group Company affect the company?

A reduction in debt of Hansoh Pharmaceutical Group Company can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of Hansoh Pharmaceutical Group Company?

Some factors that can influence the debt of Hansoh Pharmaceutical Group Company include investments, acquisitions, operating costs, and revenue development.

Why are the debts of Hansoh Pharmaceutical Group Company so important for investors?

The debts of Hansoh Pharmaceutical Group Company are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can Hansoh Pharmaceutical Group Company take to change the debt?

To change the debt, Hansoh Pharmaceutical Group Company can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does Hansoh Pharmaceutical Group Company pay?

Over the past 12 months, Hansoh Pharmaceutical Group Company paid a dividend of 0.19 CNY . This corresponds to a dividend yield of about 1.15 %. For the coming 12 months, Hansoh Pharmaceutical Group Company is expected to pay a dividend of 0.2 CNY.

What is the dividend yield of Hansoh Pharmaceutical Group Company?

The current dividend yield of Hansoh Pharmaceutical Group Company is 1.15 %.

When does Hansoh Pharmaceutical Group Company pay dividends?

Hansoh Pharmaceutical Group Company pays a quarterly dividend. This is distributed in the months of October, July, October, July.

How secure is the dividend of Hansoh Pharmaceutical Group Company?

Hansoh Pharmaceutical Group Company paid dividends every year for the past 0 years.

What is the dividend of Hansoh Pharmaceutical Group Company?

For the upcoming 12 months, dividends amounting to 0.2 CNY are expected. This corresponds to a dividend yield of 1.23 %.

In which sector is Hansoh Pharmaceutical Group Company located?

Hansoh Pharmaceutical Group Company is assigned to the 'Health' sector.

Wann musste ich die Aktien von Hansoh Pharmaceutical Group Company kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Hansoh Pharmaceutical Group Company from 7/17/2024 amounting to 0.142 CNY, you needed to have the stock in your portfolio before the ex-date on 6/19/2024.

When did Hansoh Pharmaceutical Group Company pay the last dividend?

The last dividend was paid out on 7/17/2024.

What was the dividend of Hansoh Pharmaceutical Group Company in the year 2023?

In the year 2023, Hansoh Pharmaceutical Group Company distributed 0.23 CNY as dividends.

In which currency does Hansoh Pharmaceutical Group Company pay out the dividend?

The dividends of Hansoh Pharmaceutical Group Company are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Hansoh Pharmaceutical Group Company

Our stock analysis for Hansoh Pharmaceutical Group Company Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Hansoh Pharmaceutical Group Company Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.